{"Lipid": [0], "nanoparticles": [1, 171], "(LNPs)": [2], "have": [3, 60], "emerged": [4], "across": [5], "the": [6, 20, 26, 106, 147, 151, 173, 238], "pharmaceutical": [7], "industry": [8], "as": [9, 22, 74, 164, 184, 189, 212, 225], "promising": [10], "vehicles": [11], "to": [12, 41, 65, 97, 102, 109, 223], "deliver": [13, 100], "a": [14, 32, 50, 114, 119, 125, 132, 226], "variety": [15, 126], "of": [16, 25, 47, 57, 70, 124, 127, 134, 146, 155], "therapeutics.": [17], "Currently": [18], "in": [19, 35, 181, 208, 232], "spotlight": [21], "vital": [23], "components": [24], "COVID-19": [27], "mRNA": [28, 40], "vaccines,": [29], "LNPs": [30, 117], "play": [31], "key": [33], "role": [34], "effectively": [36], "protecting": [37], "and": [38, 63, 81, 90, 99, 108, 140, 168, 191, 195, 202, 217, 237], "transporting": [39], "cells.": [42], "Liposomes,": [43], "an": [44], "early": [45], "version": [46], "LNPs,": [48], "are": [49, 161, 199, 205], "versatile": [51], "nanomedicine": [52], "delivery": [53, 186, 197], "platform.": [54], "A": [55], "number": [56], "liposomal": [58], "drugs": [59], "been": [61], "approved": [62], "applied": [64], "medical": [66, 213], "practice.": [67], "Subsequent": [68], "generations": [69], "lipid": [71, 76, 79, 166, 170], "nanocarriers,": [72], "such": [73, 163, 188, 211], "solid": [75, 169], "nanoparticles,": [77], "nanostructured": [78, 165], "carriers,": [80], "cationic": [82], "lipid\u2013nucleic": [83], "acid": [84, 193], "complexes,": [85], "exhibit": [86], "more": [87], "complex": [88], "architectures": [89], "enhanced": [91], "physical": [92], "stabilities.": [93], "With": [94], "their": [95, 111, 235, 243], "ability": [96], "encapsulate": [98], "therapeutics": [101, 194], "specific": [103], "locations": [104], "within": [105], "body": [107], "release": [110], "contents": [112], "at": [113], "desired": [115], "time,": [116], "provide": [118], "valuable": [120], "platform": [121], "for": [122, 176, 229, 242], "treatment": [123], "diseases.": [128], "Here,": [129], "we": [130], "present": [131], "landscape": [133], "LNP-related": [135], "scientific": [136, 157], "publications,": [137], "including": [138], "patents": [139], "journal": [141], "articles,": [142], "based": [143], "on": [144], "analysis": [145], "CAS": [148], "Content": [149], "Collection,": [150], "largest": [152], "human-curated": [153], "collection": [154], "published": [156], "knowledge.": [158], "Rising": [159], "trends": [160], "identified,": [162], "carriers": [167], "becoming": [172], "preferred": [174], "platforms": [175], "numerous": [177], "formulations.": [178], "Recent": [179], "advancements": [180], "LNP": [182, 233], "formulations": [183], "drug": [185], "platforms,": [187], "antitumor": [190], "nucleic": [192], "vaccine": [196], "systems,": [198], "discussed.": [200], "Challenges": [201], "growth": [203], "opportunities": [204], "also": [206], "evaluated": [207], "other": [209], "areas,": [210], "imaging,": [214], "cosmetics,": [215], "nutrition,": [216], "agrochemicals.": [218], "This": [219], "report": [220], "is": [221], "intended": [222], "serve": [224], "useful": [227], "resource": [228], "those": [230], "interested": [231], "nanotechnologies,": [234], "applications,": [236], "global": [239], "research": [240], "effort": [241], "development.": [244]}